Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 13 Pain, Postoperative 10 Neoplasms 8 Agnosia 8 Multiple Myeloma 7 Cancer Pain 5 Breast Neoplasms 5 Lung Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Trigger Finger Disorder 2 Lymphoma 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Ganglion Cysts 2 De Quervain Disease 2 Chronic Pain 2 Burkitt Lymphoma 2 Acute Pain 2 Vomiting 1 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Strabismus 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Renal Insufficiency 1

Interventions

Ketamine 3 Morphine 2 Methadone 2 Dexmedetomidine 2 ziconotide 1 substance P-saporin 1 Sodium Chloride 1 Ropivacaine 1 Registries 1 Passive Cutaneous Anaphylaxis 1 Midazolam 1 Lidocaine 1 Infusion Pumps, Implantable 1 Hydromorphone 1 Calcium Dobesilate 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pain, Intractable × Acetaminophen × Clear all

NCT04096391 2022-05-18

Prosper-001

Evolve Restorative Center

Phase NA Completed

Pain, Intractable, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡